Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing

Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing

March 3, 2010

IRVINE, CA - Avrio Biopharmaceuticals, LLC, a premier contract development and manufacturing organization, announced the addition of Yvonne Verburgt as Vice President of Business Development and Marketing. Yvonne brings over 28 years of pharmaceutical industry experience to the company and to the clients it serves. 

"We are very excited to bring Yvonne on board," said Assad J. Kazeminy, President and Founder of Avrio Biopharmaceuticals. "Yvonne brings years of experience with a remarkable track record to our executive team. She is an innovative and seasoned scientific sales leader and I look forward to the great contributions she will bring to the company and our clients."

Yvonne's most recent venture as the head of Business Development at Pharmatek Laboratories, Inc. involved successfully leading the sales team to help expand business of pharmaceutical chemistry development services. Her previous work experience includes serving as the Director of North American Sales for Patheon, Inc., and holding similar sales and management roles for companies including Oread, Inc., Becton Dickinson, Behring Diagnostics, Abbott Laboratories, and Johnson & Johnson.

"Yvonne's extensive history in science and sales makes her an ideal addition to our executive team," said Aryo A. Nikopour, Vice President of Scientific and Technical Services. "She brings an impressive depth of knowledge and leadership skills and will be instrumental in building our customer-centric business."

You can learn more about Avrio and the executive team at the upcoming 2010 PDA Annual Meeting, booth 714.

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).

 

Avrio Biopharmaceuticals

4 Chrysler

Irvine, California 92618

T: (866) 98-AVRIO (28746)

F: (949) 462-0821

www.avriobiopharma.com

 

Irvine Pharmaceutical Services

10 Vanderbilt

Irvine, California 92618

T: (877) 445-6554

F: (949) 951-4909

www.irvinepharma.com

Suggested Articles

The analysis found Nexvax2 was no better than placebo at protecting patients from gluten, prompting the Arch-backed biotech to stop the study.

Johns Hopkins scientists found that misfolded alpha-synuclein protein can travel from the gut and drive Parkinson's disease.

The financing sets Sanifit up to take its lead drug through phase 3 while exploring its potential in other progressive vascular calcification disorders.